Article
Process development for production of non-originator NISTmAb from CHO and NS0 cell lines
22 May 2025
Abstract excerpt
Cell lines that produce non-originator versions of the National Institute of Standards and Technology (NIST) monoclonal antibody reference material 8671 (NISTmAb) are invaluable to the biopharmaceutical industry because, unlike typical commercial cell lines, they can be used on a collaborative and noncompetitive basis for bioprocess development. NIST has generated NS0 clones, NISTCHO research-grade test material...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
